GlassScriptPhysician profile
Mahdi Doumet
NPI 1801880471
$4,763.58
in general payments reported to CMS, 2019-2025
46 companies · $663 in 2025
The $663 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $387 · 2021: $577 · 2022: $651 · 2023: $872 · 2024: $549 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,083.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $783.43 | 2019-2025 | Ozempic, Wegovy |
| Pfizer INC. | $684.65 | 2019-2024 | |
| Exact Sciences Corporation | $379.78 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $274.39 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Janssen Pharmaceuticals, INC | $253.84 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $218.78 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $179.60 | 2021-2025 | Vraylar |
| Abbott Laboratories | $169.06 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $143.08 | 2020-2025 | Mounjaro |
| Amgen INC. | $137.72 | 2019-2025 | Repatha, Evenity, Prolia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $120.90 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $112.67 | 2019-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.68 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.13 | 2019-2024 | Xifaxan |
| Biocompatibles, INC. | $91.72 | 2019 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahdi Doumet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.